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Characterization of orphan enzymes, for which the
catalytic functions and actual substrates are still not
elucidated, is a significant challenge in the postge-
nomic era. Here, we describe a general strategy for
exploring the catalytic potentials of orphan monoox-
ygenases basedondirect infusion analysis by Fourier
transform ion cyclotron resonance mass spectro-
metry (FT-ICR/MS). Eight cytochromes P450 from
Bacillus subtilis were recombinantly expressed in
Escherichia coli and subjected to a reconstitution
system containing appropriate electron transfer
components and many potential substrates. The re-
action mixtures were directly analyzed using FT-
ICR/MS, and substrates of the putative enzymes
were readily identified from the mass spectral data.
This allowed identification of previously unreported
CYP109B1 substrates and the functional assignment
of two putative cytochromes P450, CYP107J1 and
CYP134A1. The FT-ICR/MS-based approach can be
easily applied to large-scale screening with the aid
of the extremely high mass resolution and accuracy.
INTRODUCTION
Genome sequences of organisms are being determined at an ac-
celerating rate. The human genome was completely sequenced
in 2003, and the genome sequences of more than 500 microor-
ganisms are now available (Genomes OnLine Database, v 2.0,
http://www.genomesonline.org/). These sequences combined
with functional genomics approaches should help understand
biological systems. In addition, the genome sequences include
many genes encoding enzymes that may be useful as novel bio-
catalysts. Based on homologies with functionally characterized
enzymes, it is possible to predict the general functions of puta-
tive enzymes, although sequence information alone is not suffi-
cient to determine their catalytic functions or actual substrates.
Therefore, a robust platform to explore the catalytic potentials
of such putative enzymes should be helpful not only in basic bio-Chemistry & Biologchemical research but also in the development of biotechnolog-
ical applications.
The performance of mass spectrometers has been improving
rapidly, allowing its application to all fields of life science re-
search. Currently, Fourier transform ion cyclotron resonance
mass spectrometry (FT-ICR/MS) has the highestmass resolution
and accuracy (Marshall et al., 1998). Its high mass resolution ca-
pability (>100,000) allows nominally isobaric components to be
separated and enables direct infusion analyses of complex mix-
tures, eliminating the need for time-consuming chromatographic
separations. In addition, its high mass accuracy (<2 ppm), with
m/z values as low as three to five decimal places, enables imme-
diate identification of known components and determination of
the elemental compositions of unknowns in a complex mixture.
These advantages of FT-ICR/MS have been widely exploited
for high-throughput analyses of complex mixtures. For example,
FT-ICR/MS has been applied to proteomics and metabolomics
studies (Aharoni et al., 2002; Oikawa et al., 2006; Qian et al.,
2004). It has also been applied to analyses of compound mix-
tures such as combinatorial libraries (Schmid et al., 2000–
2001; Walk et al., 1999). FT-ICR/MS is also useful for screening
compound libraries for ligands of proteins and for characteriza-
tion of protein-ligand complexes, which are a key part of drug
discovery research (Cheng et al., 1995; Hofstadler and
Sannes-Lowery, 2006; Wigger et al., 2002). In contrast to the
analysis of protein-ligand complexes, only a few groups have ap-
plied FT-ICR/MS for the study of enzyme-substrate relation-
ships. For example, Wigger et al. (1997) and Schmid et al.
(2002) assessed the substrate specificities of a glutathione-S-
transferase and a peptidyl-cysteine decarboxylase, respec-
tively, using FT-ICR/MS. Also, Wang et al. (2001, 2002) used
FT-ICR/MS to screen combinatorial libraries for optimal
substrates of a peptide deformylase and a protein tyrosine phos-
phatase.
Monooxygenases introduce a single oxygen atom derived
frommolecular oxygen into an organicmolecule. These enzymes
play a variety of roles in the oxidative metabolism of endogenous
and exogenous compounds. There are several families of mono-
oxygenases, including cytochrome P450 (CYP) monooxyge-
nases (Nelson et al., 1996), flavoprotein monooxygenases (van
Berkel et al., 2006), two-component monooxygenases (Furuya
et al., 2004), and diiron monooxygenases (Leahy et al., 2003).y 15, 563–572, June 2008 ª2008 Elsevier Ltd All rights reserved 563
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Characterization of Orphan MonooxygenasesThe CYPs, in particular, display a wide range of functions across
species and are found in animals, plants, and microorganisms
(Nelson et al., 1996). For example, there are approximately 57
CYP genes in Homo sapiens, 273 in Arabidopsis thaliana, 150
in Phanerochaete chrysosporium, and 20 in Mycobacterium tu-
berculosis. Human and pathogen CYPs are promising therapeu-
tic targets, and the discovery of their substrates facilitates the
design of specific inhibitors (McLean et al., 2007; Schuster and
Bernhardt, 2007). In addition, this large pool of putative CYP
genes has attracted attention as a resource for new, versatile
biocatalysts (Bernhardt, 2006; Urlacher and Eiben, 2006).
As in the case of other enzyme classes, sequence information
alone does not allow determination of their catalytic functions or
actual substrates. Thus, a large number of monooxygenases re-
main ‘‘orphans’’ in the sense that their functions are still not elu-
cidated (Stark and Guengerich, 2007). Here, we describe a sys-
tem using direct infusion FT-ICR/MS for exploring the catalytic
potentials of such orphan monooxygenases. This system is con-
stituted of the reactions of these enzymes with complex com-
pound mixtures and the following direct infusion analyses, and
streamlines the process of screening for their substrates and
reaction products. The analysis of a sample, from injection to
completion of data processing, is complete within 10 min. The
millimass accuracy enables immediate identification of monoox-
ygenation products in a reactionmixture containingmany poten-
tial substrates. Stable isotope labeling with 18O of the products,
which has an accuracy sufficient for recognizing the mass differ-
ence between 18O (17.999 u) and 16OH2 (18.011 u), was used to
verify the newly identified activities. Furthermore, the candidate
structures of monooxygenation products were studied using
MS/MS analyses.
In the present study, we chose all of the eight CYP ORFs in the
genome of Bacillus subtilis as model monooxygenase genes.
CYP monooxygenases of the genus Bacillus are promising can-
didates for biocatalysts and have been well studied (Virus et al.,
2006). We employed a mixture of 30 commercially available
compounds, including terpenoids and polyketides, as a library
of potential substrates. We succeeded in identifying novel
catalytic activities of CYP109B1 and the two putative CYPs,
CYP107J1 and CYP134A1. This FT-ICR/MS-based platform
can be easily adapted to large-scale screening needed in the
genome-wide characterization of orphan monooxygenases.
RESULTS AND DISCUSSION
Cloning and Expression of B. subtilis CYP Genes
Analysis of the B. subtilis genome sequence revealed eight CYP
genes, yfnJ (CYP102A2), yrhJ (CYP102A3), bioI (CYP107H1),
yrdE (CYP107J1), pksS (CYP107K1), yjiB (CYP109B1), cypX
(CYP134A1), and ybdT (CYP152A1). Of these, CYP102A2
(Budde et al., 2004; Gustafsson et al., 2004), CYP102A3 (Gus-
tafsson et al., 2004; Lentz et al., 2004), CYP107H1 (Stok and
De Voss, 2000), andCYP152A1 (Matsunaga et al., 1999) were re-
ported to catalyze different types of fatty acid monooxygenation.
Also, CYP107K1 is involved in bacillaene metabolism (Reddick
et al., 2007). In addition, CYP109B1 was reported to hydroxylate
compactin to pravastatin (Endo et al., 2000), and recently, it was
also reported to hydroxylate testosterone (Agematu et al., 2006).
The functions of CYP107J1 and CYP134A1 remain unknown.564 Chemistry & Biology 15, 563–572, June 2008 ª2008 Elsevier LtIn this study, we cloned the eight CYP genes by PCR (Table 1).
The sequences were identical to those previously determined by
the genome sequencing project and further sequence analysis
(Kunst et al., 1997; Reddick et al., 2007). The eight CYP genes
were cloned into pET vectors and expressed in E. coli BL21
Star (DE3) under control of the T7 promoter. SDS-PAGE of
cell-free extracts from the recombinant cells revealed major
bands corresponding to the predicted molecular weights of the
CYPs (data not shown). In addition, the CO-reduced difference
spectra were characteristic of correctly folded CYPs, with Soret
absorption peaks at around 450 nm (Figure 1).
FT-ICR/MS Analysis of a Compound Mixture
As a library of potential substrates, we collected 30 compounds,
including 24 triterpenes (steroids), 2 diterpenes (abietic acid and
ginkgolide A), 2 sesquiterpenes (a-santonin and abscisic acid),
and 2 polyketides (flavone and compactin) (Table 2). Monooxy-
genation products of terpenoids and polyketides may be useful
as pharmaceutical intermediates (Mahato and Garai, 1997; Mat-
suoka et al., 1989). We then prepared a mixture of the 30 com-
pounds to give a final concentration of 100 mM (3.3 mM each).
The mixture was directly infused (i.e., without chromatographic
separation) into an electrospray ionization source of an FT-ICR
mass spectrometer (Figure 2). The mass spectral data revealed
[M+H]+ and/or [M+Na]+ peaks for the 30 compounds in the
positive ion mode. Except for the structural isomers, the peaks
for these compounds were clearly separated. For example, the
peaks for medroxyprogesterone acetate ([M+Na]+, m/z =
409.235) and compactin ([M+H]+, m/z = 409.259) were clearly
separated although the mass difference between them was
only 0.024 (Figure 2, inset). It was confirmed that mass errors
for all of the components in themixture were less than 0.001 after
external mass calibration (i.e., without internal mass calibration;
see the Experimental Procedures). The observed difference in
peak intensity was due to different ionization efficiencies of the
components. Unknown peaks were also detected, possibly
due to adduct ion formation and contamination from solvents
and instruments (Aharoni et al., 2002; Oikawa et al., 2006).
Nevertheless, FT-ICR/MS achieved clear separation of the
peaks, including noise, and allowed the immediate identification
of the 30 compounds based on precise determination of their
mass values.
Screening of CYP Substrates Using FT-ICR/MS
To discover substrates, each of the eight CYPs was reacted with
the 30-compound mixture. CYP102A2 and CYP102A3 are self-
sufficient monooxygenases consisting of a heme domain and
a diflavin reductase domain (Budde et al., 2004; Gustafsson
et al., 2004; Lentz et al., 2004). The others include only a heme
domain and require appropriate electron transfer components
for catalytic activity. The genome sequence and previous publi-
cations do not provide clear information on B. subtilis electron
transfer components coupling with these CYPs. Thus, we used
putidaredoxin (Pdx) and its reductase (PdR) from Pseudomonas
putida and Spinach ferredoxin (Fdx) and its reductase (FdR) as
electron transfer components for the B. subtilis CYPs. These
electron transfer components have been reported to couple
with several bacterial CYP enzymes (Agematu et al., 2006; Trigui
et al., 2004). After the reactions, the mixtures were directlyd All rights reserved
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Characterization of Orphan MonooxygenasesTable 1. Genes Cloned in This Study and Primer Sequences for Gene Cloning
Gene Accession Numbera Primer Sequence (50 to 30)b Digestionc
CYP102A2 CAB12544 TGAAGGAAACAAGCCCGATTCCTC (forward) (Blunt)
CGCGGATCCCTATATCCCTGCCCAGACATC (reverse) BamHI
CYP102A3 CAB14658 TGAAACAGGCAAGCGCAATACCTC (forward) (Blunt)
CCGGAATTCTTACATTCCTGTCCAAACGTC (reverse) EcoRI
CYP107H1 CAB14997 GAATTCCATATGACAATTGCATCGTCAACT (forward) NdeI
CGCGGATCCTTATTCAAAAGTCACCGGCAG (reverse) BamHI
CYP107J1 CAB14615 GAATTCACATGTCTTCAAAAGAAAAAAAGA (forward) PciI
CGCGGATCCTTAAAAACTAATCGGCAGTTC (reverse) BamHI
CYP107K1 ABQ22962 TGCAAATGGAAAAATTGATGTTTC (forward) (Blunt)
CGCGGATCCTTATTTTGAAAGTGAAACAGG (reverse) BamHI
CYP109B1 CAB13078 GAATTCTCATGAATGTGTTAAACCGCCGGC (forward) BspHI
CGCGGATCCTTACATTTTCACACGGAAGCT (reverse) BamHI
CYP134A1 CAB15511 TGAGCCAATCGATTAAATTGTTTA (forward) (Blunt)
CCGGAATTCTTATGCCCCGTCAAACGCAAC (reverse) EcoRI
CYP152A1 CAB12004 GAATTCCATATGAATGAGCAGATTCCACAT (forward) NdeI
CGCGGATCCTTAACTTTTTCGTCTGATTCC (reverse) BamHI
Pdx P00259 TTCCATATGTCTAAAGTAGTGTATGTGTCA (forward) NdeI
CACAAGCTTTTACCATTGCCTATCGGGAAC (reverse) HindIII
PdR P16640 TTCCATATGAACGCAAACGACAACGTGGTC (forward) NdeI
CACGAGCTCTCAGGCACTACTCAGTTCAGC (reverse) SacI
aNCBI accession numbers for protein are indicated.
bRestriction sites are underlined, and initiation and termination codons indicated in bold.
c See Experimental Procedures.analyzed using FT-ICR/MS as described previously. Substrates
of monooxygenases were identified through a three-step proce-
dure. First, their substrates were identified from the mass spec-
tral data, judging from the appearance of their monooxygena-
tion-product peaks with exact mass values. Second, the
predicted activities were confirmed by stable isotope labeling
with 18O, leading to peak shifts of the products by the exact
mass difference between 18O (17.999 u) and 16O (15.995 u). Fi-
nally, the activities were confirmed by reaction with each single
candidate compound in place of the compound mixture.
CYP109B1 has been reported to catalyze the monooxygena-
tion of compactin and testosterone (Agematu et al., 2006;
Endo et al., 2000). We therefore used these reactions to validate
the ability of our FT-ICR/MS-based method. Pdx and PdR were
used as the electron transfer components. As shown in Figure 3,
a monooxygenated compactin peak ([M+Na]+, m/z = 447.236)
appeared in the reaction mixture for CYP109B1, and the peak
was not detected after the reaction in the absence of the en-
zyme. Similarly, [M+H]+ and [M+Na]+ peaks corresponding to
monooxygenated testosterone appeared in the reaction mixture
for CYP109B1 (data not shown). The stable isotope labeling with
18O led to peak shifts of the products by the exact mass differ-
ence between 18O and 16O (Figure 3). These activities were fur-
ther confirmed by reaction with each single compound (compac-
tin or testosterone) in place of the compound mixture (data not
shown). In addition to compactin and testosterone, CYP109B1
unexpectedly catalyzed the monooxygenation of several ste-
roids, namely, androsta-1,4-diene-3,17-dione, norethindrone,
methyltestosterone, medroxyprogesterone acetate, testoster-Chemistry & Biologyone enanthate, and betamethasone dipropionate (Table 2). Be-
causemethyltestosterone and abietic acid are structural isomers
(Table 2), we examined which of the two is the actual substrate
using either of the compounds alone. This analysis revealed
that CYP109B1 catalyzes the monooxygenation of methyltes-
tosterone.
We next applied this method to screen the catalytic potentials
of the other CYPs. CYP107J1 in the presence of Pdx and PdR
selectively monooxygenated testosterone enanthate (Table 2).
In addition, CYP134A1 catalyzed the monooxygenation of an-
drosta-1,4-diene-3,17-dione, methyltestosterone, and proges-
terone (Table 2). Although this CYP did not exhibit detectable ac-
tivities toward these compounds when Pdx and PdR were used
as the electron transfer components, it did catalyze their mono-
oxygenation in the presence of Fdx and FdR. To our knowledge,
this is the first report of the catalytic functions and substrates for
CYP107J1 and CYP134A1. These results demonstrated the use-
fulness of this method for discovering substrates of monooxyge-
nases.
The other five CYP enzymes, CYP102A2, CYP102A3,
CYP107H1, CYP107K1, and CYP152A1, however, did not ex-
hibit detectable activities, suggesting that substrates for these
enzymes might not be included in the compound mixture used
in this study. CYP102A2, CYP102A3, CYP107H1, and
CYP152A1 were reported to be fatty acid monooxygenases
(Budde et al., 2004; Gustafsson et al., 2004; Lentz et al., 2004;
Matsunaga et al., 1999; Stok and De Voss, 2000). It is possible
that the pairs of electron transfer components, Pdx-PdR and
Fdx-FdR, did not effectively couple with these CYP enzymes.15, 563–572, June 2008 ª2008 Elsevier Ltd All rights reserved 565
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Characterization of Orphan MonooxygenasesIncreasing varieties of not only chemical classes of compounds
but also electron transfer components will increase the chance
of discovering substrates for monooxygenases. However, in
FT-ICR/MS analysis, the signal intensities of ions are liable to
fluctuate, especially in direct infusion analysis where ion sup-
pression effects are unavoidable (Aharoni et al., 2002; Oikawa
et al., 2006). Ion suppression is a phenomenon in which com-
pounds in a complexmixture compete with each other for ioniza-
tion, affecting their signal intensities. In this study, we set the
Figure 1. CO-Reduced Difference Spectra of Cell-Free Extracts of
B. subtilis CYPs
(A) Solid line, CYP102A2; dotted line, CYP102A3; dashed line, CYP107H1.
(B) Solid line, CYP109B1; dotted line, CYP107J1.
(C) Solid line, CYP107K1; dotted line, CYP134A1; dashed line, CYP152A1.
The protein concentrations were adjusted to 2 mg protein/ml. Concentrations
of CYPs were calculated using the extinction coefficient and were as
follows: CYP102A2, 0.21 mmol/g protein; CYP102A3, 0.22 mmol/g;
CYP107H1, 0.33 mmol/g; CYP107J1, 1.3 mmol/g; CYP107K1, 0.40 mmol/g;
CYP109B1, 1.4 mmol/g; CYP134A1, 0.12 mmol/g; CYP152A1, 0.35 mmol/g.566 Chemistry & Biology 15, 563–572, June 2008 ª2008 Elsevier Ltdthreshold for ion detection at a relatively high value (see the
Experimental Procedures). Reproducibly detectable peaks with
signal intensities over the threshold were used for further data
processing, whereas ions with low signal intensities may have
been excluded from the analyses. It is therefore possible that
a very weak monooxygenase activity might not be detected in
our experimental setup.
Preliminary Characterization of CYP107J1
and CYP134A1
To verify and quantify the monooxygenase activities, we ana-
lyzed reactions with individual compounds using high-perfor-
mance liquid chromatography (HPLC). Preliminary experiments
demonstrated that a 5 hr reaction with CYP109B1 (4.2 mM) con-
sumed 87% and 17% of 100 mM compactin and testosterone,
respectively. CYP107J1 (3.9 mM) consumed 40% of testoster-
one enanthate. CYP134A1 (0.36 mM) consumed 11%, 17%,
and 18% of androsta-1,4-diene-3,17-dione, methyltestoster-
one, and progesterone, respectively. Peaks corresponding to
the products were also detected following the reactions.
The reaction products generated by CYP107J1 and
CYP134A1were further examined usingHPLC-photodiode array
detection-FT-ICR/MS. After the reaction of CYP107J1 with tes-
tosterone enanthate, eight peaks were detected (27.3–37.9 min;
Figure 4A). These peaks were not detected after the reaction in
the absence of the enzyme. The UV spectra of these peaks
were typical for 3-keto-4-ene steroids, with absorption maxima
at around 240 nm (data not shown) (Lindholm et al., 2003). In
the chromatogram, two peaks with retention times of 34.8 and
35.8 min were found to be monooxygenated testosterone enan-
thate based on the m/z value of the [M+H]+ ion (m/z = 417.300).
Furthermore, two peakswith retention times of 36.7 and 37.9min
exhibited m/z = 415.285, corresponding to the products formed
from the substrate through one-oxygen addition and two-hydro-
gen elimination. Similarly, two peaks at 27.3 and 28.0 min (m/z =
433.295) were found to be the products formed through two-ox-
ygen addition, and the remaining two peaks at 31.4 and 33.5 min
(m/z = 431.280) were the products formed through two-oxygen
addition and two-hydrogen elimination. The MS/MS spectrum
for the peak at 34.8 min (m/z = 417.300) is shown in Figure 4C.
In addition to the parent ion, the [M+H]+ ion of the testosterone
moiety (m/z = 289.217) and the ions due to two successive
dehydrations from the testosterone moiety (m/z = 271.206 and
253.195) were detected. These three ions were also detected
for the substrate and the other seven products, suggesting
that the CYP107J1 reaction products should possess oxidative
modifications on the enanthate moiety. In other words,
CYP107J1may have selectively catalyzed themonooxygenation
on the enanthate moiety, while the other testosterone derivatives
in the compound mixture could not act as substrates for this en-
zyme (Table 2). Monooxygenases of the CYP107 family, which
share more than 40% identity in amino acid sequence, are in-
volved in biosyntheses of antibiotics (Arisawa et al., 1995; Inouye
et al., 1994; Weber et al., 1991) and biotin (Stok and De Voss,
2000) and catalyze fascinating reactions. For example,
CYP107A1 catalyzes hydroxylation in erythromycin biosynthesis
(Weber et al., 1991), CYP107C1 catalyzes epoxidation in car-
bomycin biosynthesis (Arisawa et al., 1995), and CYP107E1
catalyzes both hydroxylation and epoxidation in mycinamicinAll rights reserved
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Characterization of Orphan MonooxygenasesTable 2. Screening of B. subtilis CYP Substrates Using FT-ICR/MS
Compound Exact Mass
Substrate of Monooxygenasea
CYP109B1 CYP107J1 CYP134A1
Flavone 222.068
a-Santonin 246.126
Abscisic acid 264.136
Androsta-1,4-diene-3,17-dione 284.178 + +
Testosterone 288.209 +
Norethindrone 298.193 +
Methyltestosterone 302.225 + +
Abietic acid 302.225
Progesterone 314.225 +
11-Ketoprogesterone 328.204
Testosterone propionate 344.235
Prednisone 358.178
Aldosterone 360.194
Cortisone 360.194
Prednisolone 360.194
Medroxyprogesterone acetate 386.246 +
Betamethasone 392.200
Dexamethasone 392.200
Testosterone enanthate 400.298 + +
Prednisolone acetate 402.204
Chlormadinone acetate 404.175
Hydrocortisone acetate 404.220
Ginkgolide A 408.142
Compactin 408.251 +
Triamcinolone acetonide 434.210
Prednisolone succinate 460.210
Hydrocortisone succinate 462.225
Betamethasone valerate 476.257
Betamethasone dipropionate 504.252 +
Proscillaridin 530.288
aSubstrates of monooxygenases identified through a three-step procedure as described in Results and Discussion are indicated as positive (+).biosynthesis (Inouye et al., 1994). CYP107H1 catalyzes carbon-
carbon bond cleavage via the consecutive formation of an alco-
hol and a vicinal diol (Stok and De Voss, 2000).
Following the reaction of CYP134A1 with progesterone, we
detected three peaks (21.5, 23.3, and 24.9 min; Figure 4B).
These were found to be monooxygenated progesterones based
on the m/z value of the [M+H]+ ion (m/z = 331.227). The MS/MS
spectrum for the peak of 21.5 min (m/z = 331.227) is shown in
Figure 4D. The parent ion and the ions due to two successive de-
hydrations (m/z = 313.217 and 295.206) were detected. These
three ions were also detected for the other two products. These
results suggested that the oxygen atoms of the monooxygena-
tion products were susceptible toMS/MS fragmentation, leading
to difficulties in clarifying the monooxygenated positions (Wil-
liams et al., 1999). CYP134A1 is, to our knowledge, the first
member of the CYP134 family for which a catalytic function
has been demonstrated. Characterization of CYP107J1 and
CYP134A1, including detailed structural analyses of their reac-
tion products, is currently underway in our laboratories.Chemistry & BiologySIGNIFICANCE
Characterization of orphan enzymes remains a difficult task
in the postgenomic era. Here, we have described a general
strategy for exploring the catalytic potentials of orphan
monooxygenases based on direct infusion analysis by FT-
ICR/MS. The value of this strategy was demonstrated by
identifying novel catalytic activities of the one known and
two putative CYPs in B. subtilis. The millimass accuracy
enables immediate identification of monooxygenation prod-
ucts in a reaction mixture containing many potential
substrates. Thus, many compounds can be screened simul-
taneously within a short time. The analysis of a sample is
complete within 10 min, allowing several hundreds of en-
zymes per day to be assessed using an autosampler. Fur-
thermore, the high-sensitivity analysis requires only pico-
mole levels of samples. Our experimental design fully
exploited the advantages of FT-ICR/MS for the rapid primary
identification of catalytic activities, while the regio- and15, 563–572, June 2008 ª2008 Elsevier Ltd All rights reserved 567
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Characterization of Orphan MonooxygenasesFigure 2. FT-ICR/MS Analysis of the 30-Compound Mixture
Open and closed triangles indicate [M+H]+ and [M+Na]+ peaks of the 30 compounds, respectively. Mass scale expansion for the position is indicated with an
arrow (inset).stereoselectivity of enzymes and the stereostructure of re-
action products cannot be determined solely from mass in-
formation. Following the detection of an activity, the prod-
ucts can be further characterized by standard analytical
methods such asMS/MSandNMR. In this FT-ICR/MS-based
system, compound libraries of various chemical classes can
be employed in conjugation with the proper ionization
methods. The assay using a mixture of commercially avail-
able compoundsmay be useful not only for providing insight
into the catalytic functions of orphan monooxygenases but
also for screening these enzymes for novel biocatalysts. Fi-
nally, in this system, larger compound libraries such as com-
plex metabolites extracted from organisms can also be em-
ployed with the aid of extremely high resolving power. As
compound libraries become larger, stable isotope labeling
with 18O will become more important for identifying mono-
oxygenation products. More generally, this approach should
be applicable to other enzyme classes catalyzing reactions
accompanied by mass changes.
EXPERIMENTAL PROCEDURES
Chemicals
Androsta-1,4-diene-3,17-dione was purchased from Sigma-Aldrich (St. Louis,
MO), proscillaridin from Alexis Biochemicals (San Diego, CA), a-santonin and568 Chemistry & Biology 15, 563–572, June 2008 ª2008 Elsevier Ltginkgolide A from LKT Laboratories (St. Paul, MN), and testosterone and
11-ketoprogesterone from Tokyo Kasei (Tokyo, Japan). The other compounds
in the library (Table 2) were purchased from Wako Pure Chemicals (Osaka,
Japan). Compactin was prepared by alkaline hydrolysis of its lactone from
Wako Pure Chemicals. Fdx and FdR were purchased from Sigma-Aldrich.
18O2 was purchased from Taiyo Nippon Sanso (Tokyo, Japan). All other chem-
icals were of analytical grade.
Bacterial Strains, Plasmids, and Genomic DNAs
For cloning and expression studies, E. coli DH5a (Takara Bio, Tokyo, Japan)
and BL21 Star (DE3) (Invitrogen, Carlsbad, CA) were used as hosts, and
pET21a and pET21d (Novagen, Darmstadt, Germany) were used as vectors.
B. subtilis (ATCC 23857), whose genome sequence has been reported (Gen-
Bank accession number NC_000964), was used as the source of genomic
DNA for the cloning of CYP genes. P. putida (JCM 6157, ATCC 17453) was
used as the source of pdx and pdR genes. These strains were cultivated ac-
cording to the recommended growth conditions, and their genomic DNAs
were prepared using a DNeasy tissue kit (QIAGEN, Germantown, MD).
Cloning and Expression of CYP Genes
Analysis of the B. subtilis genome sequence revealed eight CYP genes, all of
which were cloned. The genes were amplified by PCR and ligated into
pET21a or pET21d using the primers and restriction enzymes listed in Table
1. The initiation codon of each gene was adjusted to the ATG on the pET21a
NdeI or pET21d NcoI site to express the genes under control of the T7 pro-
moter. For the cloning of the genes encoding CYP107J1 and CYP109B1, the
pET21d vectors digested with NcoI and the appropriate restriction enzymes
were used, and for the other genes, the pET21a vectors digested with NdeId All rights reserved
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Characterization of Orphan MonooxygenasesFigure 3. FT-ICR/MS Analysis of the Monooxygenation of Compactin by CYP109B1 in the Compound Mixture
Mass spectra after the reaction with CYP109B1 (+), without the enzyme (), and with CYP109B1 under 18O2 atmosphere (+ under 18O2).and the appropriate restriction enzymes were used. For the genes encoding
CYP102A2, CYP102A3, CYP107K1, and CYP134A1, the NdeI-digested sites
of pET21a vectors were bluntedwith T4DNA polymerase before ligation (Table
1). The resulting recombinant plasmids were amplified in E. coliDH5a cells and
sequenced to confirm that the correct constructs had been obtained.
For the expression of the genes, the plasmids were introduced into E. coli
BL21 Star (DE3) cells. These recombinant cells were cultivated in Luria-Bertani
medium (1% Bacto tryptone, 0.5% Bacto yeast extract, 1% NaCl [pH 7.0])
supplemented with ampicillin (100 mg ml1) at 25C. After cultivation for
12 hr, isopropyl-b-D-thiogalactopyranoside (1 mM), 5-aminolevulinic acid
(0.5 mM), and FeSO4 (0.5 mM) were added to the medium and cultivation
was continued for an additional 12 hr. The cells were harvested by centrifuga-
tion at 10,0003 g for 10 min at 4C, washed with potassium phosphate buffer
(50 mM [pH 7.5]) containing glycerol (10% v/v), and stored at 80C until use.
Preparation of the Compound Mixture
A total of 30 commercially available terpenoids and polyketides were randomly
collected as a compound library (Table 2). The 30-compound mixture (10 mM
total, 0.33mMeach) was prepared as a stock solution by dissolving each com-
pound in ethanol.
Enzymatic Reactions
Frozen cells were suspended in ammonium formate buffer (20 mM [pH 7.0])
and disrupted with an ultraoscillator. After centrifugation at 15,000 3 g for
30 min at 4C, the resulting cell-free extracts were used as enzyme solutions.
The reaction mixture (500 ml) contained a cell-free extract of recombinant
cells expressing a CYP (3 mg protein/ml), the 30-compound mixture
(100 mM total, 3.3 mM each), NADH or NADPH (5 mM), and ammonium formate
buffer (20mM [pH 7.0]). As controls, reactions were performed using a cell-free
extract of recombinant cells carrying pET21a in place of the CYP enzymeChemistry & Biologysolutions. As necessary, either the Pdx-PdR or the Fdx-FdR pair was added
to the reaction mixture as electron transfer components. The pdx and pdR
genes were individually cloned and expressed in E. coli BL21 Star (DE3) cells
(Table 1), and cell-free extracts were prepared as described previously. These
cell-free extracts (1 mg protein/ml) along with NADH were added to the re-
actions. The reactions containing the Fdx-FdR pair were supplemented with
Fdx (0.25 mg/ml), FdR (0.50 U/ml), and NADPH. Enzymatic reactions were
performed in 2 ml glass vials sealed with screw caps for 16 hr at 30C with
shaking. For stable isotope labeling with 18O, air was removed from the
enzyme-containing vials through rubber septa on the screw caps using a
vacuum pump, after which 18O2 was injected, and the reaction was initiated
by the addition of the compound mixture and NAD(P)H.
FT-ICR/MS Analysis
The reactionmixture (500 ml) was acidified by the addition of HCl (pH 1.5–2). To
the mixture, 19-norandrostenedione (5 mM) was added as an internal standard
for peak intensity. The mixture was extracted twice with ethyl acetate (1 ml).
The combined extract was evaporated and the resulting residuewas dissolved
in 10:90 formic acid (1%)/methanol (500 ml). After filtration through a 0.20 mm
pore polytetrafluoroethylene membrane (Advantec, Tokyo, Japan), the sam-
ples were analyzed using a Finnigan LTQ FT (Thermo, Waltham, MA) with
a 7 T magnet. Ions were generated using an electrospray ionization source
in the positive ion mode, which was appropriate for the ionization of the terpe-
noids and polyketides in the mixture. The mass detector was calibrated using
caffeine (Sigma-Aldrich), Met-Arg-Phe-Ala (Research Plus, Manasquan, NJ),
and UltraMark 1621 (Lancaster Synthesis, Windham, NH) prior to sample anal-
yses. After the external mass calibration, mass errors for all of the components
in the mixture were less than 0.001. The mass detector was tuned to optimize
the instrumental parameters as follows: spray voltage, 4 kV; capillary temper-
ature, 200C; capillary voltage, 8 V; tube lens offset voltage, 90 V. The mass15, 563–572, June 2008 ª2008 Elsevier Ltd All rights reserved 569
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Characterization of Orphan MonooxygenasesFigure 4. HPLC-FT-ICR/MS Analysis of the CYP107J1 and CYP134A1 Reaction Products
(A) HPLC chromatogram (254 nm) after the reaction of CYP107J1 with testosterone enanthate. The m/z value of each peak is also shown.
(B) HPLC chromatogram after the reaction of CYP134A1 with progesterone.
(C) MS/MS spectrum for the peak at 34.8 min in chromatogram (A).
(D) MS/MS spectrum for the peak at 21.5 min in chromatogram (B).resolution was set to 100,000 at m/z = 400, and the scan range was set to
m/z = 200–600. The samples were directly infused into the FT-ICR mass spec-
trometer at a flow rate of 10 ml min1 without chromatographic separation.
FT-ICR/MS Data Processing
Mass spectral data were acquired for 1 min (67 scans) and averaged. For
data processing, Metalys-OH software (Genaris, Kanagawa, Japan, http://
www.genaris.co.jp/) was used. This software can extract peaks correspond-
ing to monooxygenation products from mass spectral data based on their
exact mass values. The permissible range of mass error was set to less
than 0.001. Through the analyses, [M+H]+ and/or [M+Na]+ peaks were
detected for each compound in the positive ion mode, although the ratio
fluctuated. Thus, the total of [M+H]+ and [M+Na]+ peak intensities were cal-
culated for the monooxygenation products and 19-norandrostenedine as the
internal standard, and the values of monooxygenation products were570 Chemistry & Biology 15, 563–572, June 2008 ª2008 Elsevier Ltdcompared with that of 19-norandrostenedione. One unit was defined as
the peak intensity of 1 nM 19-norandrostenedine, and the threshold level
was set to 1,000.
HPLC-Photodiode Array Detection-FT-ICR/MS Analysis
The samples were analyzed using a HPLC-photodiode array detection system
(1100 series, Agilent, Palo Alto, CA) with an XTerra MS C18 column (4.6 mm3
250 mm; particle size, 3.5 mm; Waters, Milford, MA) connected to a Finnigan
LTQ FT. Mobile phases A and B were composed of 0.1% formic acid in water
and 0.1% formic acid in acetonitrile, respectively. The samples were eluted
with a linear gradient of 20% to 100% B for 40 min, followed by 100% B for
10 min at a flow rate of 0.5 ml/min. The mass detector was tuned to optimize
the instrumental parameters as follows: spray voltage, 4 kV; capillary temper-
ature, 300C; capillary voltage, 30 V; tube lens offset voltage, 90 V. MS/MS
analysis was carried out at a normalized collision energy of 20%.All rights reserved
Chemistry & Biology
Characterization of Orphan MonooxygenasesConcentration Measurement of Protein and CYP
Protein concentrations were measured using a Coomassie protein assay kit
(Pierce, Rockford, IL) with bovine serum albumin as the standard (Bradford,
1976). The concentrations of CYPs were measured based on CO-reduced dif-
ference spectra using an extinction coefficient of 91 mM1cm1 at 450 nm
(Omura and Sato, 1964).
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